Detalhe da pesquisa
1.
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
PLoS Biol
; 22(1): e3002463, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289907
2.
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Blood
; 143(2): 118-123, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647647
3.
Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Eur Respir J
; 54(4)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537697
4.
Three-dose vaccination elicits neutralising antibodies against omicron.
Lancet
; 399(10326): 715-717, 2022 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065005
5.
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Lancet
; 397(10292): 2331-2333, 2021 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090624
6.
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Lancet
; 398(10296): 207-209, 2021 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197809
7.
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
PLoS Biol
; 12(7): e1001906, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003521
8.
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 13(11): 1161-70, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078958
9.
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.
medRxiv
; 2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292842
10.
Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.
JAMA Dermatol
; 158(6): 641-649, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507334
11.
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial.
Clin Cancer Res
; 26(18): 4748-4755, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669375
12.
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 106(4): 733-742, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809876
13.
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Eur J Cancer
; 120: 86-96, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499384
14.
Novel CT-Based Objective Imaging Biomarkers of Long-Term Radiation-Induced Lung Damage.
Int J Radiat Oncol Biol Phys
; 102(4): 1287-1298, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908943
15.
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
BMJ Open
; 8(4): e020690, 2018 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666135
16.
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).
J Clin Oncol
; 35(14): 1506-1514, 2017 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240967
17.
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
J Clin Oncol
; 35(4): 402-411, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893326
18.
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 95(5): 1367-1377, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296040
19.
Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases.
J Natl Cancer Inst
; 106(7)2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25031274